HETLIOZ Trademark

Trademark Overview

On Thursday, July 28, 2011, a trademark application was filed for HETLIOZ with the United States Patent and Trademark Office. The USPTO has given the HETLIOZ trademark a serial number of 85383242. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, April 8, 2024. This trademark is owned by Vanda Pharmaceuticals Inc.. The HETLIOZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, and diseases and disorders having a central nervous system manifestation
hetlioz

General Information

Serial Number85383242
Word MarkHETLIOZ
Filing DateThursday, July 28, 2011
Status800 - REGISTERED AND RENEWED
Status DateMonday, April 8, 2024
Registration Number4552099
Registration DateTuesday, June 17, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, and diseases and disorders having a central nervous system manifestation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 2, 2011
Primary Code005
First Use Anywhere DateTuesday, April 15, 2014
First Use In Commerce DateTuesday, April 15, 2014

Trademark Owner History

Party NameVanda Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037
Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037
Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, August 1, 2011NEW APPLICATION ENTERED
Tuesday, August 2, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 7, 2011ASSIGNED TO EXAMINER
Monday, September 12, 2011PRIORITY ACTION WRITTEN
Tuesday, September 13, 2011PRIORITY ACTION MAILED
Thursday, March 8, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 8, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 9, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 28, 2012ASSIGNED TO LIE
Wednesday, March 28, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 11, 2012NOTICE OF PUBLICATION
Tuesday, May 1, 2012PUBLISHED FOR OPPOSITION
Tuesday, June 26, 2012NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 13, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 13, 2012SOU TEAS EXTENSION RECEIVED
Thursday, December 13, 2012SOU EXTENSION 1 FILED
Thursday, December 27, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 27, 2012SOU EXTENSION 1 GRANTED
Friday, December 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 11, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, June 11, 2013SOU EXTENSION 2 FILED
Monday, June 24, 2013SOU EXTENSION 2 GRANTED
Tuesday, June 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2013SOU TEAS EXTENSION RECEIVED
Wednesday, November 20, 2013SOU EXTENSION 3 FILED
Saturday, November 30, 2013SOU EXTENSION 3 GRANTED
Tuesday, December 3, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 23, 2014TEAS STATEMENT OF USE RECEIVED
Wednesday, April 23, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, April 23, 2014SOU EXTENSION 4 FILED
Wednesday, April 23, 2014USE AMENDMENT FILED
Tuesday, April 29, 2014SOU EXTENSION 4 GRANTED
Tuesday, April 29, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 30, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 9, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 9, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, May 10, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 17, 2014REGISTERED-PRINCIPAL REGISTER
Monday, June 17, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 29, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, December 2, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 3, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 3, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, June 17, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, November 22, 2023TEAS SECTION 8 & 9 RECEIVED
Monday, April 8, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 8, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, April 8, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, April 8, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

hetlioz nervous system disorders central diseases having manifestation impact preparations pharmaceutical